Latest News about BTAI
Recent news which mentions BTAI
From Benzinga
Why Is BioXcel Therapeutics (BTAI) Stock Down 57% Today?
June 29, 2023
From InvestorPlace
From InvestorPlace
From InvestorPlace
Goldman Sachs Maintains Neutral Rating for BioXcel Therapeutics: Here's What You Need To Know
May 26, 2023
Tickers
BTAI
From Benzinga
From Benzinga
Why Dollar Tree Shares Are Trading Lower By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
May 25, 2023
From Benzinga
Tickers
BTAI
From Motley Fool
From MarketWatch
BioXcel Therapeutics Reports Encouraging Phase 1b Results For Innovative Depression Treatment
May 16, 2023
Tickers
BTAI
From Benzinga
From Motley Fool
From Benzinga
From Benzinga
From Benzinga
BioXcel Therapeutics Unveils Complete Data From BXCL701/Keytruda Combo Study In Prostate Cancer Subtype
February 14, 2023
From Benzinga
Analyst Reiterates This Alzheimer's Candidate As Top Idea For 2023
February 08, 2023
From Benzinga
2 Beaten-Down Stocks to Watch Closely Next Year
December 06, 2022
From Motley Fool
Why BioXcel Therapeutics Stock Triumphed This Week
December 02, 2022
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For December 1, 2022
December 01, 2022
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.